Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/18/25 17:12 | 6/16/25 | ONC | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | V8 | O | SVP,GC | 2 | S | -292 | 260.02 | 0 | -1 | 0 | 278 | D | ||||||||||||||
6/18/25 17:10 | 6/16/25 | ONC | Health | Drug | Pharmaceutical Preparations | Wang Lai | V8 | O | Global H | 2 | S.m | -786 | 257.64 | 0 | -3 | 0 | 1,769 | D | ||||||||||||||
6/18/25 17:08 | 6/16/25 | ONC | Health | Drug | Pharmaceutical Preparations | Wu Xiaobin | V8 | O | P,COO | 3 | S.dm | -15,668 | 279.64 | 0 | -56 | 1,262 | D | |||||||||||||||
6/18/25 17:06 | 6/16/25 | ONC | Health | Drug | Pharmaceutical Preparations | Oyler John | V8 | DO | CEO | 2 | S.m | -2,649 | 258.06 | 0 | -10 | 0 | 54,270 | D | ||||||||||||||
6/12/25 17:51 | 6/11/25 | ONC | Health | Drug | Pharmaceutical Preparations | Ball Titus B. | V8 | O | Principa | 1 | S | -35 | 258.36 | 0 | 0 | 0 | 74 | D | ||||||||||||||
6/12/25 17:39 | 6/10/25 | ONC | Health | Drug | Pharmaceutical Preparations | Wang Xiaodong | V8 | DH | Chair, S | 3 | S.d | -30,442 | 242.99 | 0 | -125 | 10,159 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |